Rash acneiform; Psoriasis aggravated /Psoriasis flare-up; Alcohol intolerance; Chills; Generalized aching; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS ACNEIFORM (Rash acneiform), PAIN (Generalized aching), PSORIASIS (Psoriasis aggravated /Psoriasis flare-up), ALCOHOL INTOLERANCE (Alcohol intolerance) and CHILLS (Chills) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    In Nov 2020, the patient reported he had Covid-19 with symptoms of chills, body aches, cough, headache and lost appetite. He had plaque psoriasis flare up with red spots on face, that looked like acne, and itches. White pus and after draining, drainage looked like yellow crystals. He also got flakey scalp from drinking beer, plaques on right ring finger.  The patient's past medical history included COVID-19 in November 2020 and Appetite lost in November 2020. Concurrent medical conditions included Plaque psoriasis.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) 1 dosage form. In 2021, the patient experienced PAIN (Generalized aching) and CHILLS (Chills). On an unknown date, the patient experienced DERMATITIS ACNEIFORM (Rash acneiform), PSORIASIS (Psoriasis aggravated /Psoriasis flare-up) and ALCOHOL INTOLERANCE (Alcohol intolerance). In 2021, PAIN (Generalized aching) and CHILLS (Chills) had resolved. At the time of the report, DERMATITIS ACNEIFORM (Rash acneiform) had not resolved and PSORIASIS (Psoriasis aggravated /Psoriasis flare-up) and ALCOHOL INTOLERANCE (Alcohol intolerance) outcome was unknown.            No concomitant medication information was provided.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  Patient had red spots on face, that looks like acne, and itches. White puss and after draining, drainage looks like yellow crystals. First dose caused chills, and body aches, lasted eight to ten hours.  No treatment medication information was provided.  The reporter's causality for the event(s) of CHILLS AFTER COVID VACCINE, BODY ACHES AFTER COVID VACCINE, ILL FEELING AFTER COVID VACCINE, COVID-19, LOSS OF APPETITE, PLAQUE PSORIASIS FLARE UP and FEELING OF BEING RUN DOWN AFTER COVID VACCINE was not provided. The reporter's causality for the event(s) of FATIGUE with SKYRIZI(RISANKIZUMAB) was no reasonable possibility.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-631705 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2022: Follow up Significant Information received, Age was updated, medical history was updated, Start date of Moderna vaccine was updated. Psoriasis aggravated, and Alcohol intolerance were added as an events. Chills outcome was updated. Start date for Pain and chills was updated, Stop date of Pain was updated. Reporter causality was updated. On 11-Mar-2022: Significant follow up appended. Start date of vaccine was updated. Outcome for Psoriasis aggravated /Psoriasis flare-up was updated.